IP Verse

Compositions And Methods For Increasing The Serum Half Life Of A Therapeutic Agent Targeting Complement C5 - EP2978451

PATENT ANALYSIS

Patent Details

Grant Date
Nov 27, 2019
Company
ALEXION PHARMACEUTICALS, INC.
Oppositions

ALNYLAM PHARMACEUTICALS, INC.

REGENERON PHARMACEUTICALS, INC.

More patents of Alexion Pharmaceuticals, Inc.

EP3167888

EP2894165

EP2978451

Want to monitor this patent?

Feel free to send us a message here and we will get back to you